| 今开：0.7 | 昨收：0.71 |
| 最高：0.7646 | 最低：0.7 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3328157.0 |
Aptevo Therapeutics(APVO)01-31 07:05
$Aptevo Therapeutics(APVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-009002 Size: 6 KB 网页链接查看全文
Aptevo Therapeutics(APVO)01-31 07:15
$Aptevo Therapeutics(APVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-009003 Size: 6 KB 网页链接查看全文
Aptevo Therapeutics(APVO)02-07 05:45
$Aptevo Therapeutics(APVO)$ 8-K Current report, item 5.07 Accession Number: 0000950170-24-011766 Act: 34 Size: 168 KB 网页链接查看全文
Aptevo Therapeutics(APVO)03-05 21:25
$Aptevo Therapeutics(APVO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-025427 Act: 34 Size: 340 KB 网页链接查看全文
Aptevo Therapeutics(APVO)03-05 21:35
$Aptevo Therapeutics(APVO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-025428 Act: 34 Size: 11 MB 网页链接查看全文
Aptevo Therapeutics(APVO)03-06 05:15
$Aptevo Therapeutics(APVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025881 Size: 10 KB 网页链接查看全文
Aptevo Therapeutics(APVO)03-06 05:15
$Aptevo Therapeutics(APVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025915 Size: 10 KB 网页链接查看全文
Aptevo Therapeutics(APVO)03-06 06:15
$Aptevo Therapeutics(APVO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0000950170-24-026223 Act: 34 Size: 186 KB 网页链接查看全文
Aptevo Therapeutics(APVO)01-31 07:15
$Aptevo Therapeutics(APVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-009005 Size: 6 KB 网页链接查看全文
Aptevo Therapeutics(APVO)03-07 22:05
$Aptevo Therapeutics(APVO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-027613 Act: 34 Size: 204 KB 网页链接查看全文
$Aptevo Therapeutics(APVO)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-046911 Act: 34 Size: 2 MB 网页链接
$Aptevo Therapeutics(APVO)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-046881 Act: 34 Size: 3 MB 网页链接
$Aptevo Therapeutics(APVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-046896 Act: 34 Size: 655 KB 网页链接
$Aptevo Therapeutics(APVO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0000950170-24-044419 Act: 34 Size: 1 MB 网页链接
$Aptevo Therapeutics(APVO)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0000950170-24-044148 Act: 33 Size: 1 MB 网页链接
$Aptevo Therapeutics(APVO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000919 Act: 33 Size: 1 KB 网页链接
$Aptevo Therapeutics(APVO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0000950170-24-043059 Act: 33 Size: 1 MB 网页链接
$Aptevo Therapeutics(APVO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0000950170-24-038743 Act: 33 Size: 1 MB 网页链接
$Aptevo Therapeutics(APVO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0000950170-24-034178 Act: 33 Size: 2 MB 网页链接
$Aptevo Therapeutics(APVO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-027613 Act: 34 Size: 204 KB 网页链接